Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Aurora Mirabile; Rosalba Miceli; Rosa Gioia Calderone; Laura Locati; Paolo Bossi; Cristiana Bergamini; Roberta Granata; Federica Perrone; Luigi Mariani; Lisa Licitra

doi:10.1002/hed.25636

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck

Head & Neck ◽

10.1002/hed.25636 ◽

2019 ◽

Vol 41 (6) ◽

pp. 1895-1902 ◽

Cited By ~ 1

Author(s):

Aurora Mirabile ◽

Rosalba Miceli ◽

Rosa Gioia Calderone ◽

Laura Locati ◽

Paolo Bossi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

960P A real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: A prospective observation study (JROSG12-2)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1075 ◽

2020 ◽

Vol 31 ◽

pp. S678-S679

Author(s):

T. Yokota ◽

Y. Ota ◽

H. Fujii ◽

T. Kodaira ◽

M. Shimokawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Head And Neck ◽

Clinical Outcomes ◽

Squamous Cell ◽

Real World ◽

Japanese Patients ◽

Observation Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2)

International Journal of Clinical Oncology ◽

10.1007/s10147-020-01817-4 ◽

2020 ◽

Author(s):

Tomoya Yokota ◽

Yosuke Ota ◽

Hirofumi Fujii ◽

Takeshi Kodaira ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Head And Neck ◽

Clinical Outcomes ◽

Squamous Cell ◽

Real World ◽

Japanese Patients ◽

Observation Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734912521.793555705 ◽

2019 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Second Line ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

MO3-2 Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck

Annals of Oncology ◽

10.1016/j.annonc.2021.05.565 ◽

2021 ◽

Vol 32 ◽

pp. S296

Author(s):

Ari Nishimura ◽

Tomoya Yokota ◽

Yoshiyuki Iida ◽

Tomoyuki Kamijo ◽

Takashi Mukaigawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Prognostic Significance ◽

Metastatic Squamous Cell Carcinoma ◽

Metastatic Sites

Download Full-text

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix

European Journal of Cancer ◽

10.1016/j.ejca.2004.12.013 ◽

2005 ◽

Vol 41 (4) ◽

pp. 523-530 ◽

Cited By ~ 65

Author(s):

Jennifer J. Knox ◽

Lillian L. Siu ◽

Eric Chen ◽

Jim Dimitroulakos ◽

Suzanne Kamel-Reid ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Prolonged Administration ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Observational study of the cetuximab relative dose intensity (RDI) in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Data on the maintenance and every two weeks use (DIRECT study)

Annals of Oncology ◽

10.1093/annonc/mdw376.19 ◽

2016 ◽

Vol 27 ◽

pp. vi334 ◽

Cited By ~ 2

Author(s):

J. Guigay ◽

E. Chamorey ◽

P. Céruse ◽

F. Mornex ◽

M. Degardin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Observational Study ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Dose Intensity ◽

Line Treatment ◽

First Line ◽

Metastatic Squamous Cell Carcinoma ◽

First Line Treatment

Download Full-text

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens

Oral Oncology ◽

10.1016/j.oraloncology.2010.08.013 ◽

2010 ◽

Vol 46 (11) ◽

pp. 818-821 ◽

Cited By ~ 8

Author(s):

Elena Massa ◽

Mariele Dessì ◽

Giulio Gaspardini ◽

Federica Saba ◽

Valeria Cherchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text